Healthcare databases have become the cornerstone of pharmacoepidemiologic research. However, the demonstration of the product value often relies on disease-specific characteristics, such as biomarkers or laboratory test results, which are not routinely recorded in healthcare databases. On the other hand, the launch of multi-national field studies is a costly and lengthy endeavour. An option would be to utilize disease-specific databases or patient registries that are already ongoing.
Finding such fit-for-purpose database is complex considering their heterogeneity in regards to information provided and to access policy.
YOLARX has developed a scientific and turn-key solution aiming to identify existing data sources tailored to your needs.